Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06159777

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

Pre- and Post-operative Compared to Post-operative Only Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

Sponsor: University Hospitals Cleveland Medical Center

Conditions Constipation Prolapse; Female Surgical Procedure, Unspecified

Interventions Polyethylene Glycol 3350

Updated 9 times since 2024 Last updated: Jan 6, 2026 Started: Jun 5, 2024 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Constipation and Prolapse; Female and is currently actively recruiting participants. University Hospitals Cleveland Medical Center leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE4
Aug 2025 — Feb 2026 [monthly]

Recruiting PHASE4
Apr 2025 — Aug 2025 [monthly]

Recruiting PHASE4
Nov 2024 — Apr 2025 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting PHASE4

▶ Show 4 earlier versions

Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4
Apr 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE4
Jan 2024 — Apr 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States